Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP

PLoS ONE

Volumn 12, Issue 11, 2017, Pages

  Roth, Michael ^a   Pasquali, Christian ^b   Stolz, Daiana ^a   Tamm, Michael ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Vifor (International) Inc   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL EXTRACT; BACTERIUM LYSATE; BETA DEFENSIN; CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; COMPLEMENT COMPONENT C1Q RECEPTOR; COMPLEMENT RECEPTOR; CYCLIC AMP; DOCKING PROTEIN; GAMMA INTERFERON; INDUCIBLE T CELL COSTIMULATOR; INDUCIBLE T CELL COSTIMULATOR LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; OM 85; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; VIRAL PROTEIN; BRONCHO-VAXOM; CELL EXTRACT;

ADOLESCENT; ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; ASTHMA; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HBEC CELL LINE (BRONCHIAL); HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MIDDLE AGED; PROTEIN EXPRESSION; RHINOVIRUS; RHINOVIRUS INFECTION; SIGNAL TRANSDUCTION; VIRUS INHIBITION; VIRUS REPLICATION; BRONCHUS; CASE CONTROL STUDY; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; MAPK SIGNALING; METABOLISM; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHI; CASE-CONTROL STUDIES; CELL EXTRACTS; CELLS, CULTURED; CYCLIC AMP; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHINOVIRUS; VIRAL PROTEINS;

EID: 85035813115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0188010     Document Type: Article

References (46)

1. Graham LM, Eid N. The impact of asthma exacerbations and preventive strategies. Curr Med Res Opin. 2015; 9: 1–11.
2. Cazzola M, Noschese P, Di Perna F. Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone. Ther Adv Respir Dis. 2009; 3:59–63. https://doi.org/10.1177/1753465809104677 PMID: 19443519
3. Razi CH, Harmancı K, Abacı A, Özdemir O, Hızlı S, Renda R, et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol. 2010; 126:763–9. https://doi.org/10.1016/j.jaci.2010.07.038 PMID: 20920766
4. Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr. 2010; 6:5–12. https://doi.org/10.1007/s12519-010-0001-x PMID: 20143206
5. Anthonisen NR. OM-85 BV for COPD. Am J Respir Crit Care Med 1997; 156:97.
6. Bessler WG, Vor dem Esche U, Masihi N. The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection. Int Immunopharmacol. 2010; 10(9):1086–90. https://doi.org/10.1016/j.intimp.2010.06.009 PMID: 20601184
7. Navarro S, Cossalter G, Chiavaroli C, Kanda A, Fleury S, Lazzari A, et al. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol. 2011; 4:53–65. https://doi.org/10.1038/mi.2010.51 PMID: 20811345
8. Bowman LM, Holt PG. Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract. Infect Immun. 2001; 69(6):3719–27. https://doi.org/10.1128/IAI.69.6.3719-3727.2001 PMID: 11349036
9. Han L, Zheng CP, Sun YQ, Xu G, Wen W, Fu QL. A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice. Am J Rhinol Allergy. 2014; 28(2):110–6. https://doi.org/10.2500/ajra.2013.27.4021 PMID: 24717947
10. Huber M, Mossmann H, Bessler WG. Th1-orientated immunological properties of the bacterial extract OM-85-BV. Eur J Med Res. 2005; 10(5):209–17. PMID: 15946922
11. Pasquali C, Salami O, Taneja M, Gollwitzer ES, Trompette A, Pattaroni C, et al. Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract. Front Med (Lausanne). 2014 Oct 30; 1:41. https://doi.org/10.3389/fmed.2014.00041 PMID: 25593914
12. Luan H, Zhang Q, Wang L, Wang C, Zhang M, Xu X, et al. OM85-BV induced the productions of IL-1β, IL-6, and TNF-α via TLR4- and TLR2-mediated ERK1/2/NF-κB pathway in RAW264.7 cells. J Interferon Cytokine Res. 2014; 34(7):526–36. https://doi.org/10.1089/jir.2013.0077 PMID: 24605772
13. Zelle-Rieser C, Ramoner R, Bartsch G, Thurnher M. A clinically approved oral vaccine against pneumo-tropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cells. Immunol Lett. 2001 Feb 1; 76(1):63–7. PMID: 11222915
14. Grainge CL, Davies DE. Epithelial injury and repair in airways diseases. Chest. 2013; 144:1906–12. https://doi.org/10.1378/chest.12-1944 PMID: 24297122
15. Kearney SC, Dziekiewicz M, Feleszko W. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma. Ann Allergy Asthma Immunol. 2015; 114(5):364–9. https://doi.org/10.1016/j.anai.2015.02.008 PMID: 25752734
16. Esposito S, Marchisio P, Prada E, Daleno C, Porretti L, Carsetti R, et al. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection. Vaccine. 2014; 32(22):2546–52. https://doi.org/10.1016/j.vaccine.2014.03.055 PMID: 24681270
17. Kim SH, Jang YS. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med. 2014; 46:e85. https://doi.org/10.1038/emm.2013.165 PMID: 24626171
18. Powell JJ, Faria N, Thomas-McKay E, Pele LC. Origin and fate of dietary nanoparticles and microparti-cles in the gastrointestinal tract. J Autoimmun. 2010; 34(3):J226–33. https://doi.org/10.1016/j.jaut.2009.11.006 PMID: 20096538
19. Ahrens B, Quarcoo D, Buhner S, Matricardi PM, Hamelmann E. Oral administration of bacterial lysates attenuates experimental food allergy. Int Arch AllergyImmunol. 2011; 156(2):196–204.
20. Antonova LP, Romanov VV, Averbakh MM. [Experience with bronchomunal used in the combined treatment of patients with bronchial asthma and chronic obstructive pulmonary disease]. Probl Tuberk Bolezn Legk. 2008;(4):8–11. PMID: 18509908
21. Emmerich B, Emslander HP, Pachmann K, Hallek M, Milatovic D, Busch R. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. Respiration. 1990; 57(2):90–9. PMID: 2122507
22. Parola C, Salogni L, Vaira X, Scutera S, Somma P, Salvi V, et al. Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway. PLoS One. 2013; 8(12):e82867. https://doi.org/10.1371/journal.pone.0082867 PMID: 24386121
23. Quezada A, Maggi L, Pérez MA, Rodríguez J. Effect of bacterial antigen lysate on IgG and IgA levels in children with recurrent infections and hypogammaglobulinemia. J Investig Allergol Clin Immunol. 1999; 9(3):178–82. PMID: 10412680
24. Liao JY, Zhang T. [Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection]. Zhongguo Dang Dai Er Ke Za Zhi. 2014; 16:508–12. PMID: 24857002
25. Wilson SS, Wiens ME, Smith JG. Antiviral mechanisms of human defensins. J Mol Biol. 2013; 425 (24):4965–80. https://doi.org/10.1016/j.jmb.2013.09.038 PMID: 24095897
26. Duchow J, Marchant A, Delville JP, Schandene L, Goldman M. Upregulation of adhesion molecules induced by broncho-vaxom on phagocytic cells. Int J Immunopharmacol. 1992; 14:761–6. PMID: 1355078
27. Traub S, Nikonova A, Carruthers A, Dunmore R, Vousden KA, Gogsadze L, et al. An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation. PLoS Pathog. 2013; 9: e1003520. https://doi.org/10.1371/journal.ppat.1003520 PMID: 23935498
28. Mukhopadhyay S, Malik P, Arora SK, Mukherjee TK. Intercellular adhesion molecule-1 as a drug target in asthma and rhinitis. Respirology. 2014; 19:508–13. https://doi.org/10.1111/resp.12285 PMID: 24689994
29. Qian X, Agematsu K, Freeman GJ, Tagawa Y, Sugane K, Hayashi T. The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system. Eur J Immunol. 2006; 36:906–18. https://doi.org/10.1002/eji.200535253 PMID: 16552709
30. Nazzal D, Gradolatto A, Truffault F, Bismuth J, Berrih-Aknin S. Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand. Cell Death Dis. 2014; 5:e1420. https://doi.org/10.1038/cddis.2014.377 PMID: 25210803
31. Conway EM, Liu L, Nowakowski B, Steiner-Mosonyi M, Ribeiro SP, Michalak M. Heat shock-sensitive expression of calreticulin. J Biol Chem. 1995; 270: 17011–17016. PMID: 7622522
32. Hostettler KE, Roth M, Burgess JK, Gencay MM, Gambazzi F, Black JL, et al. Airway epithelium-derived transforming growth factor-beta is a regulator of fibroblast proliferation in both fibrotic and normal subjects. Clin Exp Allergy. 2008; 38(8):1309–17. https://doi.org/10.1111/j.1365-2222.2008.03017.x PMID: 18503568
33. Oliver BG, Lim S, Wark P, Laza-Stanca V, King N, Black JL, et al. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax. 2008; 63(6):519–25. https://doi.org/10.1136/thx.2007.081752 PMID: 18245149
34. Lambers C, Roth M, Zhong J, Campregher C, Binder P, Burian B, et al. The interaction of endothelin-1 and TGF-β1 mediates vascular cell remodeling. PLoS One. 2013; 8(8):e73399. https://doi.org/10.1371/journal.pone.0073399 PMID: 24015303
35. Sun Q, Li L, Wang H, Mandal J, Khan P, Hostettler KH, et al. Constitutive high expression of PRMT1 in asthmatic airway smooth muscle cells is caused by reduced MicroRNA-19a and leads to enhanced remodelling. J Allergy Clin Immunol. 2017 Jan 9. https://doi.org/10.1016/j.jaci.2016.11.013 PMID: 28081849
36. Capetti A, Cossu MV, Carenzi L, Rizzardini G. Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patients. Hum Vaccin Immunother. 2013; 9(9):1849–51. https://doi.org/10.4161/hv.25104 PMID: 23792443
37. Coviello S, Wimmenauer V, Polack FP, Irusta PM. Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4. Hum Vaccin Immunother. 2014; 10 (10):2896–902. https://doi.org/10.4161/hv.29784 PMID: 25483455
38. Dang AT, Pasquali C, Ludigs K, Guarda G. OM-85 is an immunomodulator of interferon-β production and inflammasome activity. Sci Rep. 2017; 7:43844. https://doi.org/10.1038/srep43844 PMID: 28262817
39. Blaas D, Fuchs R. Mechanism of human rhinovirus infections. Mol Cell Pediatr. 2016 Dec; 3(1):21. https://doi.org/10.1186/s40348-016-0049-3 PMID: 27251607
40. Bochkov YA, Gern JE. Rhinoviruses and Their Receptors: Implications for Allergic Disease. Curr Allergy Asthma Rep. 2016 Apr; 16(4):30. https://doi.org/10.1007/s11882-016-0608-7 PMID: 26960297
41. Wiehler S, Proud D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol. 2007 Aug; 293(2):L505–15. https://doi.org/10.1152/ajplung.00066.2007 PMID: 17545490
42. Duits LA, Nibbering PH, van Strijen E, Vos JB, Mannesse-Lazeroms SP, van Sterkenburg MA, et al. Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol. 2003 Aug 18; 38(1):59–64. PMID: 12900056
43. Verneret M, Tacnet-Delorme P, Osman R, Awad R, Grichine A, Kleman JP, et al. Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis. J Innate Immun. 2014; 6(4): 426–434 https://doi.org/10.1159/000358834 PMID: 24557008
44. Conway EM, Liu L, Nowakowski B, Steiner-Mosonyi M, Ribeiro SP, Michalak M. Heat shock-sensitive expression of calreticulin. J Biol Chem. 1995; 270: 17011–17016 PMID: 7622522
45. Hong C, Zhang T, Gao XM. Recombinant murine calreticulin fragment 39–272 expands CD1d(hi)CD5+ IL-10-secreting B cells that modulate experimental autoimmune encephalomyelitis in C57BL/6 mice. Mol Immunol. 2013; 55(3–4): 237–246. https://doi.org/10.1016/j.molimm.2013.02.003 PMID: 23523122
46. Baruah P, Dumitriu IE, Malik TH, Cook HT, Dyson J, Scott D, et al. C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. Blood. 2009; 113 (15): 3485–3493. https://doi.org/10.1182/blood-2008-06-164392 PMID: 19171874